# Guo's Subclavian Artery Reconstruction: The Prospective, Multiple Center Study of WeFlow-Tbranch Stent Graft System(GUEST Study)

> **NCT04765605** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Hangzhou Endonom Medtech Co., Ltd.** · enrollment: 120 (actual)

## Conditions studied

- Type B Aortic Dissection

## Interventions

- **DEVICE:** WeFlow-Tbranch Stent Graft System

## Key facts

- **NCT ID:** NCT04765605
- **Lead sponsor:** Hangzhou Endonom Medtech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-12-25
- **Primary completion:** 2026-12-25
- **Final completion:** 2026-12-25
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2024-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04765605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04765605, "Guo's Subclavian Artery Reconstruction: The Prospective, Multiple Center Study of WeFlow-Tbranch Stent Graft System(GUEST Study)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04765605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*